Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Hemostemix Inc
V.HEM
Alternate Symbol(s):
HMTXF
Healthcare
Biotechnology
Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP...
-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:HEM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(81)
•••
vinneyquaw2
X
View Profile
View Bullboard History
Comment by
vinneyquaw2
on Jun 15, 2022 11:41am
RE:RE:RE:Still waiting.. When i see volume rising i might hop in
Rambo - pp supposed to close Friday probably with some news about what's going on with HEM - could be good news. Lots of little signs indicating something could be up? Might kick yourself if you
...more
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Comment by
RamboOO7
on Jun 15, 2022 10:39am
RE:RE:Still waiting.. When i see volume rising i might hop in
Good luck. I am still waiting to jump in. Volume is still too low. Hope i don't miss the boat hahahahaha
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 14, 2022 2:48pm
$HMTXF’s new operations vice president with an spotless resu
Mr. Pete Palvin who recently joined as vice president to the operations department has evaluated the performance of NASA space shuttle ASRM refurbishing reboot system with the application real time
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 14, 2022 1:17pm
$HMTXF reports private placement of 15 million units Hemost
Hemostemix in a recent press release has announced a non-brokered private placement of around 15 million units for its existing shareholders.
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 14, 2022 11:12am
$HEM has updated its financial status on TSX-Venture
Hemostemix has updated its financials and announced a non-brokered private placement of up to 15 million units priced in the market.
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 14, 2022 10:53am
Hemostemix Inc. Valuation Measures
Hemostemix Inc. is a clinical-stage biotechnology company leading on TSX-V with a market cap of $19.793M.
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Post by
ENEMENEMYNEMO
on Jun 14, 2022 10:35am
More good news!
Great to see the move on the neural cell line! HEM is getting its ducks in a row, the company is ensuring a turn-key operation to present to the market pending Pahse II results!
(26)
•••
GustheGreek
X
View Profile
View Bullboard History
Comment by
GustheGreek
on Jun 14, 2022 10:16am
RE:Still waiting.. When i see volume rising i might hop in
I bought more too... under 30 cents in my opinion, Is a bargain. GLTA!
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 14, 2022 8:22am
New Press Release - Hemostemix Announces the Incorporation of PreCerv Inc. And a Global Field of Use License to NCP-01
Calgary, Alberta--(Newsfile Corp. - June 14, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has incorporated PreCerv Inc. ("PreCerv"), as a wholly owned subsidiary. PreCerv will obtain from Hemostemix a global field of use license to...
read article.
(147)
•••
RamboOO7
X
View Profile
View Bullboard History
Post by
RamboOO7
on Jun 13, 2022 4:50pm
Still waiting.. When i see volume rising i might hop in
GLTA
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 12:44pm
Hemostemix Inc. Market Insights
Hemostemix Inc. is a publicly-traded biotech company, with the ticker symbol as $HMTXF, listed on the OTC Market, having a reasonable market cap of 16M, marked a open today $0.2234.
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 12:24pm
Hemostemix Market Impression
The company deals with the CLI treatment which is specifically developing, manufacturing, and commercializing innovative blood-derived stem cell therapies. Listed on the OTC platform with $HMTXF as
...more
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 12:13pm
Hemostemix Inc. stock updates
Hemostemix Inc., (OTCQB: $HMTXF) is a Canada-based biotech company, listed on the OTC Market with the ticker symbol as $HMTXF, having a decent market cap 16M, marked a open today at $0.2234.
(24)
•••
robert345
X
View Profile
View Bullboard History
Post by
robert345
on Jun 13, 2022 12:07pm
The closure of convertible debenture
Hemostemix closed the previously released convertible debenture offering the $1,000 principal amount of each offering. https://www.newsfilecorp.com/redirect/PMjmQc7qye
(67)
•••
Jon9800
X
View Profile
View Bullboard History
Post by
Jon9800
on Jun 13, 2022 11:51am
Hemostemix market value
$HMTXF holding its ground amid price fluctuation with an incredible market cap of 16 million+.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >